Pages that link to "Q29622839"
Jump to navigation
Jump to search
The following pages link to Heterogeneity in cancer: cancer stem cells versus clonal evolution (Q29622839):
Displaying 50 items.
- Evolutionary dynamics of cancer in response to targeted combination therapy (Q21128788) (← links)
- Genomic restructuring in the Tasmanian devil facial tumour: chromosome painting and gene mapping provide clues to evolution of a transmissible tumour (Q21144931) (← links)
- Salinomycin as a drug for targeting human cancer stem cells (Q21285139) (← links)
- Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271 (Q24617636) (← links)
- Single-cell dissection of transcriptional heterogeneity in human colon tumors (Q24628796) (← links)
- Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2 (Q24628857) (← links)
- Wnt5a Signaling in Cancer (Q26738408) (← links)
- Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy (Q26740207) (← links)
- Stem cell technology in breast cancer: current status and potential applications (Q26746223) (← links)
- Cancer Stem Cell Hierarchy in Glioblastoma Multiforme (Q26752312) (← links)
- Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment (Q26783055) (← links)
- Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors (Q26783710) (← links)
- Insights into Chemoresistance of Prostate Cancer (Q26795589) (← links)
- Increased Oxidative Stress as a Selective Anticancer Therapy (Q26798210) (← links)
- Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia (Q26799954) (← links)
- Evolutionary determinants of cancer (Q26801710) (← links)
- Side population cells as prototype of chemoresistant, tumor-initiating cells (Q26823433) (← links)
- The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? (Q26824147) (← links)
- Tumor heterogeneity and its implication for drug delivery (Q26829096) (← links)
- Frizzled7 as an emerging target for cancer therapy (Q26849278) (← links)
- Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma (Q26849546) (← links)
- Glioblastoma cancer stem cells: Biomarker and therapeutic advances (Q26859782) (← links)
- Nanocarriers for diagnosis and targeting of breast cancer (Q26862309) (← links)
- On the origin of cancer metastasis (Q26865675) (← links)
- Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis (Q26991480) (← links)
- Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma (Q26998068) (← links)
- Breast cancer intra-tumor heterogeneity (Q27000086) (← links)
- Brain tumor stem cells: Molecular characteristics and their impact on therapy (Q27003138) (← links)
- Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma (Q27013006) (← links)
- Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives (Q27014117) (← links)
- Can nanomedicines kill cancer stem cells? (Q27022017) (← links)
- A new prospect in cancer therapy: targeting cancer stem cells to eradicate cancer (Q27022134) (← links)
- Cancer stem cells--the current status of an old concept: literature review and clinical approaches (Q27025165) (← links)
- Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia (Q27309004) (← links)
- Tumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progenies (Q27318628) (← links)
- Modeling evolutionary dynamics of epigenetic mutations in hierarchically organized tumors (Q27333860) (← links)
- Dynamics between cancer cell subpopulations reveals a model coordinating with both hierarchical and stochastic concepts (Q27334912) (← links)
- Microfabricated physical spatial gradients for investigating cell migration and invasion dynamics (Q27335397) (← links)
- Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787 (Q27700015) (← links)
- Bidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneity (Q28066409) (← links)
- Mammary gland stem cells and their application in breast cancer (Q28075791) (← links)
- MicroRNAs targeting prostate cancer stem cells (Q28081039) (← links)
- Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells (Q28084243) (← links)
- Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone (Q28251767) (← links)
- Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer (Q28291499) (← links)
- The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma (Q28307211) (← links)
- Novel insights into the molecular origins and treatment of lung cancer (Q28386773) (← links)
- Down-regulation of DNA mismatch repair enhances initiation and growth of neuroblastoma and brain tumour multicellular spheroids (Q28478209) (← links)
- Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma (Q28478709) (← links)
- Distinguishing between exploratory and confirmatory preclinical research will improve translation (Q28538978) (← links)